Evaluating buprenorphine prescribing and opioid-related health outcomes following the expansion the buprenorphine waiver program

Volume: 132, Pages: 108452 - 108452
Published: Jan 1, 2022
Abstract
AimsTo evaluate associations between new types of buprenorphine waivers (nurse practitioner and physician assistant [NP/PA]; 275-patient limit [MD/DO-275]) and both buprenorphine prescribing and health outcomes.MethodsUsing comprehensive county-level data from California 2010–2018, we modeled quarterly associations between numbers of NP/PA and MD/DO-275 waivers and rates of buprenorphine prescribing, opioid-related deaths, emergency department...
Paper Details
Title
Evaluating buprenorphine prescribing and opioid-related health outcomes following the expansion the buprenorphine waiver program
Published Date
Jan 1, 2022
Volume
132
Pages
108452 - 108452
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.